 patients) and
over a mean follow-up of 62 months restenosis risk
greater than 70%/occlusion was 10% (95% CI, 6.0-16.3) in
patients having CAS. The same study showed that over a
mean of 50 months of surveillance, 1 of 125 CAS patients
(0.8%) with restenosis greater than 70%/occlusion suffered a